Product Information
EZETIMIBE-SIMVASTATIN 10-10 MG is a generic product labeled by Ascend Laboratories, LLC, priced at $0.3283 per EA under NDC 67877050730. Its NADAC has been published 441 times since Mar 14, 2018.
FDA first approved this application on Dec 22, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 10 mg/1; mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877050730
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA209222FDA Approved
12/22/2017
TE Code
AB
On Market Since
12/24/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has been published 441 times since Mar 14, 2018, and over the history we have for it it has declined 89.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3283 per EA |
|---|---|
| All-time high | $3.1958 (Mar 14, 2018) |
| All-time low | $0.2356 (Apr 19, 2023) |
| 52-week high | $0.3810 |
| 52-week low | $0.2639 |
| Median price | $0.5924 |
| Average price | $0.9530 |
| Largest weekly change | +75.7% (May 17, 2023) |
| Weeks tracked | 441 |
| Tracking since | Mar 14, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-10 MG, manufactured by Ascend Laboratories, LLC, is $0.3283 per EA (NDC 67877050730), effective Aug 19, 2026.
How has the price of EZETIMIBE-SIMVASTATIN 10-10 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has declined 89.7%. It has been tracked across 441 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-10 MG?
Since Mar 14, 2018, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has ranged from a low of $0.2356 (Apr 19, 2023) to a high of $3.1958 (Mar 14, 2018), with a median of $0.5924 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-10 MG?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-10 MG, is $0.3246 per EA — about 1% below EZETIMIBE-SIMVASTATIN 10-10 MG.
Who manufactures EZETIMIBE-SIMVASTATIN 10-10 MG?
EZETIMIBE-SIMVASTATIN 10-10 MG (NDC 67877050730) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.